STAT3 and breast carcinoma: Indeed, MAT1 has been reported to promote breast cancer progression and metastasis by altering signaling pathways [92], including the activation of STAT3 transcription [93] and repression of SMAD7 transcription to ensure the TGFβ signaling [94].